Profusa vies for potential G3 Vision Labs acquisition
If the acquisition goes ahead, Profusa will add several routine chemistry, toxicology and pathology diagnostic offerings to its portfolio.
03 August 2026
03 August 2026
If the acquisition goes ahead, Profusa will add several routine chemistry, toxicology and pathology diagnostic offerings to its portfolio.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.